|
|
||||||||
Article |
1 From the Department of Exercise Science, School of Public Health, University of South Carolina, Columbia, SC
2 Address reprint requests to JM Davis, Department of Exercise Science, University of South Carolina, Blatt Center, Wheat Street, Columbia, SC 29208.
| ABSTRACT |
|---|
|
|
|---|
Key Words: Central fatigue nutrition prolonged exercise carbohydrates branched-chain amino acids serotonin dopamine tryptophan
| INTRODUCTION |
|---|
|
|
|---|
Both types of fatigue (peripheral and central) can potentially occur in individuals at rest and during vigorous exercise. With individuals in a rested state or performing low-intensity daily activities, peripheral fatigue is less likely to occur because fuel is readily available and acidosis within the muscle is low. CNS mechanisms are more likely to promote fatigue experienced during normal daily activities. Furthermore, feelings of fatigue are a common feature in situations such as postoperative recovery, jet lag, sleep deprivation, post-meal drowsiness, and chronic fatigue syndrome, all of which do not apparently involve muscle defects. Because the mechanisms of fatigue in these situations are not well understood, it is often thought that nothing can be done to alleviate their effects.
Investigators, however, have now begun to focus more heavily on possible mechanisms of fatigue involving the CNS. The most direct evidence of central fatigue has been generated through the use of a new analytic technique, transcranial magnetic stimulation. With this technique, magnetically generated stimulation of the motor cortex elicits an action potential to the alpha motor neuron of the spinal column and, in turn, to the neuromuscular junction. Direct evidence of inhibition of central drive after exercise is now available (57). Previously, evidence of central fatigue was commonly acknowledged only by default when there was no evidence of specific muscle impairment.
It has long been known that nutritional status can alter brain neurochemistry [especially that involving carbohydrates and the neurotransmitter serotonin, or hydroxytryptamine (5-HT)], in conjunction with various psychologic and other disorders, including depression, premenstrual syndrome, sleepiness, impaired perceptual and cognitive function, and seasonal affective disorder, all of which include fatigue as a common symptom (810). It is therefore tempting to suggest a possible role of nutrition in central fatigue that is evoked by exercise. However, during exercise, many of the variables thought to regulate an effect of nutrition on brain 5-HT do not respond in the same fashion as they would under resting conditions (discussed further in a later section of this paper). This phenomenon, along with the lack of good techniques to distinguish between central and peripheral fatigue during exercise has severely limited scientific study in this area (3). Nevertheless, there are now intriguing theories and some evidence to support a possible role of nutrition in central fatigue. This review focuses primarily on current research on possible nutritional strategies that may influence brain 5-HT and central fatigue during exercise.
| THE CENTRAL FATIGUE HYPOTHESIS |
|---|
|
|
|---|
Increased synthesis of 5-HT in the brain occurs in response to an increase in the delivery of blood-borne tryptophan (TRP), an amino acid precursor to 5-HT. Most of the TRP in blood plasma circulates loosely bound to albumin; however, unbound, or free, TRP (f-TRP) is transported across the blood-brain barrier. This transport occurs via specific receptors that TRP shares with other large neutral amino acids, most notably the branched-chain amino acids (BCAAs) leucine, isoleucine, and valine. Thus, 5-HT synthesis in the brain increases when there is an increase in the ratio of the f-TRP concentration in blood plasma to the total BCAA concentration in plasma (ie, when f-TRP:BCAA rises). This increase was proposed to occur during prolonged exercise for 2 reasons. First, BCAAs are taken up from blood and oxidized for energy during contraction of skeletal muscles. Second, fatty acid (FA) concentrations in plasma increase, causing a parallel increase in plasma f-TRP because FAs displace TRP from its binding sites on albumin (Figure 1
).
|
| BRAIN 5-HT AND CENTRAL FATIGUE DURING EXERCISE |
|---|
|
|
|---|
The serotonergic system is associated with numerous brain functions that can positively or negatively affect endurance performance. We have observed that fatigue during prolonged exercise in rats is associated with increased 5-HT and reduced dopamine concentrations in the brain (19). Other evidence has shown an inverse relationship between 5-HT and dopamine in certain brain areas. On the basis of these findings, it is our working hypothesis that a low ratio of brain 5-HT to dopamine favors improved performance (ie, increased arousal, motivation, and optimal neuromuscular coordination), whereas a high ratio of 5-HT to dopamine favors decreased performance (ie, decreased motivation, lethargy, tiredness, and loss of motor coordination) (3). The latter would constitute central fatigue.
Chaouloff et al (2022) were the first to demonstrate an effect of treadmill exercise on the ratio of f-TRP to BCAA in plasma, as well as on the concentrations of 5-HT and its primary metabolite 5-hydroxyindole acetic acid (5-HIAA) in the brain. Chaouloff et al (21, 22) initially showed that the total concentration of TRP in plasma was unaffected in rats after 12 h of treadmill running (20 m/min). However, the concentration of f-TRP in plasma was markedly increased and was accompanied by an increase in TRP and 5-HIAA concentrations in the brain. Similar changes were found in cerebrospinal fluid, and concentrations returned to basal amounts by 1 h after exercise (23). The same authors (24) also found that endurance-trained rats that had undergone repeated sessions of prolonged exercise showed increased turnover of plasma FA, brain TRP, and brain 5-HT immediately after exercise, but that this increase was smaller than that found in less well-trained rats. This was the first evidence that endurance running is associated with an increase in 5-HT production and turnover, which in turn is due to an increase in plasma f-TRP.
We began to look more carefully at the possible relationship between elevated 5-HT concentrations in the brain and fatigue. One experiment was designed to study the time course of changes in brain neurotransmitters during exercise to fatigue (19). Rats were killed at points corresponding to rest, after 1 h of treadmill running (1 h) and at fatigue (approximately 3 h). The treadmill speed (20 m/min) and grade (5%) were set to elicit
6065% of
O2max. The midbrain, striatum, hypothalamus, and hippocampus were analyzed for concentrations of 5-HT and dopamine and their primary metabolites, 5-HIAA and Dopac (3,4-dihydroxyphenylacetic acid). In the 1-h group, 5-HT and 5-HIAA concentrations were increased in all brain regions except the hippocampus, where only 5-HIAA was elevated. In the fatigue group, 5-HT was similarly elevated in all brain regions, but 5-HIAA was further increased in the striatum and the midbrain. Interestingly, dopamine and Dopac both increased at 1 h but had returned to control amounts after fatigue. These results indicate that 5-HT and 5-HIAA concentrations increase during endurance exercise and are highest at fatigue.
The aforementioned studies provide good evidence of increased 5-HT and 5-HIAA concentrations in whole brain tissue at specific time points during prolonged exercise. However, these studies do not differentiate between intra- and extracellular concentrations, which is necessary to determine whether the changes are due to the release of 5-HT from the serotonergic neuron terminals. Techniques involving in vivo microdialysis have been used to examine this issue and support the conclusion that increased release of 5-HT occurs in various regions of the brain (25, 26). However, no such studies have been conducted during fatiguing exercise. Further development of this technique should provide exciting new avenues for exploration of central fatigue in the exercise model.
A better cause and effect relationship between increased brain 5-HT and fatigue was demonstrated in a series of experiments involving pharmacologic alterations in brain 5-HT activity during exercise in rats (19, 27). We proposed that if 5-HT could be artificially increased through the administration of 5-HT agonists (drugs that specifically increase 5-HT activity), fatigue would occur earlier. In contrast, if 5-HT antagonists (drugs that decrease brain 5-HT activity) were administered, fatigue would be delayed. The experiments demonstrated that run time to exhaustion decreased after the administration of specific 5-HT agonists but increased after the administration of a 5-HT antagonist (27). These modulations in run time to fatigue occurred despite no apparent alterations in body temperature, blood glucose, muscle and liver glycogen, or various stress hormones (27).
Similar studies were conducted with human subjects in which brain 5-HT activity was increased by the administration of either of the 5-HT agonists paroxetine (28) or fluoxetine (29). Fatigue occurred earlier during running or cycling, and ratings of perceived exertion were higher when the drugs were administered than when a placebo was administered. As in the animal studies, there were no obvious differences in cardiovascular, thermoregulatory, or metabolic function that could explain the differences in exercise time to fatigue.
| NUTRITION, 5-HT, AND CENTRAL FATIGUE DURING EXERCISE |
|---|
|
|
|---|
|
In well-controlled laboratory experiments, the administration of BCAA showed to have no benefits on performance during prolonged bouts of exercise. Using a double-blinded, crossover design, Varnier et al (33) found no differences in performance of a graded incremental exercise test to fatigue after the infusion of
20 g of BCAA or saline over 70 min before exercise. Additionally, Verger et al (34) reported that fatigue occurred earlier during prolonged treadmill running in rats fed relatively large amounts of BCAAs than in those fed either water or glucose.
To further assess the potential role of BCAA supplementation on exercise performance, Blomstrand et al (35) devised a cycle ergometry protocol for trained athletes in a controlled laboratory study. In this study, 5 endurance-trained male cyclists performed cycle ergometer exercise to fatigue at 75%
O2 peak, preceded by a glycogen-reducing activity. On separate occasions, subjects were randomly given (a) BCAA (7 g/L1) in a 6% CHO solution, (b) 6% CHO solution, or (c) flavored water placebo. Increases in performance were seen in subjects given CHO and in those given BCAA in CHO solution as compared with those given placebo. Results further indicated no additional benefits of the added BCAA despite increases in BCAA concentrations in plasma (120%) and muscle (35%).
In another well-controlled study, van Hall et al (36) tested the effects of both TRP and BCAA supplementation on cycling time to fatigue. Ten endurance-trained athletes randomly completed a session of cycle ergometry exercise to fatigue at 7075% of their maximal power output after being given (a) low concentrations of BCAA (6 g/L1) in 6% CHO, (b) high concentrations of BCAA (18 g/L1) in 6% CHO, or (c) TRP (36 g/L1) in a 6% CHO solution. Despite large changes in plasma concentrations of BCAA and total TRP, exercise time to exhaustion (
122 min) was not different among treatments. The authors concluded that these manipulations either had no additional effect on serotonergic activity in the brain or that manipulation of serotonergic activity functionally does not contribute to mechanisms of fatigue. This brings up an important issue regarding the presumed effect of supplementation on brain neurochemistry, which of course cannot be directly assessed in human studies.
We completed a pilot study in rats that addresses this issue in part (37). We tested the effects of BCAA or CHO feedings on 5-HT and 5-HIAA concentrations in the midbrain and striatum after 60, 90, and 120 min of treadmill running. No concentration differences were found in either brain region at 60 and 90 min. At 120 min, however, 5-HT and 5-HIAA concentrations were lower in the brainstem in both the BCAA and the CHO groups than in a water-fed group. 5-HT concentrations in the striatum were also lower in the CHO group at 120 min. Whether these changes reflect differences in central fatigue awaits further study.
For BCAAs to be physiologically effective in reducing central fatigue, large doses are probably required. Large doses, however, are likely to increase the ammonia concentration in plasma, which is known to be toxic to the brain and muscle (36). It has been suggested that buffering of ammonia could lead to early fatigue in working muscles by depleting glycolytically derived carbon skeletons (pyruvate) and draining intermediates of the tricarboxylic acid cycle (38). Large doses of BCAA during exercise are also likely to slow water absorption across the gut, cause gastrointestinal disturbances, and decrease fluid palatability.
To assess the effects of a smaller, more palatable supplement of BCAAs (
0.5 g x h1 BCAA consumed in a CHO-electrolyte drink), we studied the effects of supplementation on cycling performance to fatigue at 70%
O2 max (39). This low dose of BCAA was chosen to replace the calculated maximum amount of BCAA uptake and metabolism by muscle that was likely to occur under these conditions; and to decrease the likelihood that the BCAA supplements would impair water absorption rates in the gut, produce gastrointestinal distress, or otherwise be unpalatable. The results of this study showed that the low-dose BCAA supplement added to a CHO-electrolyte drink was palatable, did not cause gastrointestinal distress, and prevented the slight drop in BCAA concentration in plasma that occurred during prolonged cycling when subjects consumed the CHO-electrolyte drink without the BCAA supplement. However, the added BCAAs did not affect ride times to fatigue, perceived exertion, or various measures of cardiovascular and metabolic function.
It seems reasonably clear from the weight of the evidence in the literature that BCAA supplementation is probably not an appropriate nutritional strategy for delaying central fatigue and enhancing performance. On the other hand, the literature is consistent in showing beneficial effects of CHO feedings during prolonged exercise when compared with a water placebo. This is not surprising, given the well-known benefit of CHO feedings on muscle metabolism and fatigue. It is also possible, however, that CHO feedings can delay central fatigue. Therefore, a more appropriate strategy for delaying both peripheral and central fatigue might involve CHO feedings.
We tested this hypothesis in a double-blind, placebo-controlled laboratory study in which subjects drank either 5 ml of a water placebo, a 6% CHO-electrolyte drink, or a 12% CHO-electrolyte drink per kilogram of body weight per hour during prolonged cycling at 70%
O2 max to fatigue (17). When subjects consumed the water placebo, plasma f-TRP increased by 7-fold (in direct proportion to plasma FAs), whereas TRP and BCAA concentrations changed very little during the ride. When subjects consumed either the 6% or the 12% CHO-electrolyte solution, the increases in plasma f-TRP were greatly reduced, and fatigue was delayed by
1 h. The CHO feedings caused a slight reduction in plasma BCAAs (19% and 31% in the 6% and 12% CHO groups, respectively), but this decrease was probably inconsequential with respect to the very large attenuation (57-fold) of plasma f-TRP (17). Although it was not possible to distinguish between the beneficial effects of CHO feedings on central compared with peripheral mechanisms of fatigue in this study, it was interesting that the substantial delay in fatigue could not be explained by typical markers of peripheral muscle fatigue involving cardiovascular, thermoregulatory, and metabolic function.
| SUMMARY |
|---|
|
|
|---|
Fatigue-related research generally includes an examination of treatments designed to delay fatigue and enhance physical performance. This often involves nutritional strategies that supply extra fuel to the working muscle or buffer the buildup of toxic metabolic by-products. A possible role of nutrition in central fatigue is also beginning to emerge in the scientific literature. Nutritional strategies designed to alter brain 5-HT metabolism have received the most attention in this regard. Although 5-HT is probably not the only neurotransmitter involved in central fatigue during prolonged exercise, a review of the mechanisms involved in the control of 5-HT synthesis and turnover in the brain make it a particularly attractive candidate. Newsholme et al (11) first proposed this neurotransmitter as a potential mediator of central fatigue in 1987. It is well known that increases in brain 5-HT can have important effects on arousal, lethargy, sleepiness, and mood that could be linked to altered perception of effort and muscular fatigue.
It is now known that 5-HT and its major metabolite, 5-HIAA, increase in several brain regions during prolonged exercise and reach a peak at fatigue. This increase in brain 5-HT metabolism almost certainly results from an increase in f-TRP and f-TRP-to-BCAA ratio in plasma. It is also known that the administration of drugs that increase and decrease 5-HT activity in the brain have predictable effects on run times to fatigue in the absence of any apparent peripheral markers of muscle fatigue.
The evidence, however, is more tenuous regarding a benefit of nutrition on central fatigue during exercise. Studies involving BCAA supplementation usually show no performance benefit despite preliminary evidence that it can suppress brain 5-HT metabolism during exercise. Perhaps the negative effects of ammonia accumulation on muscle and brain function offset this potentially beneficial effect on brain 5-HT. CHO supplementation, in contrast, is associated with large decreases in f-TRP and f-TRP-to-BCAA ratio in plasma and with a decrease in 5-HT metabolism in the brain, and fatigue is clearly delayed by this strategy. However, it is not possible to distinguish with certainty the effects of CHO feedings on central fatigue mechanisms and the well-established beneficial effects of CHO supplementation on the contracting muscle.
Future research on possible relations among nutrition, brain neurochemistry, and fatigue is likely to lead to important discoveries that may enhance physical and mental performance during sports participation as well as during activities of normal daily life. This research should begin to incorporate new technologies involving transcranial magnetic stimulation, in vivo microdialysis, novel drugs, and various new dynamic imaging technologies, including positron emission tomography for measuring neurotransmitter metabolism and receptor changes. The resulting information may also help us to understand and better treat the debilitating fatigue that often occurs in patients with chronic fatigue syndrome, fibromyalgia, viral illness, and depression, among other disorders. Although the evidence usually makes good intuitive sense, however, our knowledge in this area is rudimentary at best.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. R. Abbiss, J. J. Peiffer, J. M. Peake, K. Nosaka, K. Suzuki, D. T. Martin, and P. B. Laursen Effect of carbohydrate ingestion and ambient temperature on muscle fatigue development in endurance-trained male cyclists J Appl Physiol, April 1, 2008; 104(4): 1021 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Peeters, B. Driessen, and R. Geers Influence of supplemental magnesium, tryptophan, vitamin C, vitamin E, and herbs on stress responses and pork quality J Anim Sci, July 1, 2006; 84(7): 1827 - 1838. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Smriga, M. Kameishi, and K. Torii Exercise-Dependent Preference for a Mixture of Branched-Chain Amino Acids and Homeostatic Control of Brain Serotonin in Exercising Rats J. Nutr., February 1, 2006; 136(2): 548S - 552S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fernstrom and M. H. Fernstrom Exercise, Serum Free Tryptophan, and Central Fatigue J. Nutr., February 1, 2006; 136(2): 553S - 559S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Payne A Neuroendocrine-Based Regulatory Fatigue Model Biol Res Nurs, October 1, 2004; 6(2): 141 - 150. [Abstract] [PDF] |
||||
![]() |
L. Nybo, B. Nielsen, E. Blomstrand, K. Moller, and N. Secher Neurohumoral responses during prolonged exercise in humans J Appl Physiol, September 1, 2003; 95(3): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R Lieberman, C. M Falco, and S. S Slade Carbohydrate administration during a day of sustained aerobic activity improves vigilance, as assessed by a novel ambulatory monitoring device, and mood Am. J. Clinical Nutrition, July 1, 2002; 76(1): 120 - 127. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |